Skip to content
Modern Playhouse

Users Stopping Anti-Obesity Medications Gain Back Weight Far More Rapidly Compared to People Using Diet and Exercise

Image of pharmaceutical injection and weighing machine
Weight management involves ongoing approaches.

Fresh analysis reveals that people who discontinue blockbuster slimming jabs like semaglutide or tirzepatide may regain shed pounds far faster than those who halt traditional lifestyle programs.

Research printed in a major medical journal demonstrates that while obese people can lose a large proportion of their body weight while undergoing treatment, the weight is regained at an estimated rate of nearly a kilo each month after stopping.

"Individuals buying such drugs must be informed of the risk of fast weight regain when the treatment concludes," warns lead investigator Dr. Susan Jebb.

That rate of regain implies a return to starting weight within about one and a half years.

Comparing Approaches

The analysis, which looked at dozens of trials involving thousands of participants, contrasted the effects of the injectable medications with other pills.

Researchers emphasize that people who lose weight through diet and exercise typically have a more gradual creep back—perhaps 100 grams monthly—after stopping.

The Reason for the Fast Regain

Nutrition scientists suggest the way of the injections accounts for the heightened rebound.

These medications imitate a natural hormone called GLP-1, which helps regulate hunger.

"Sustained high doses of the hormone concentrations several times higher than normal could lead to the system to generate a reduced amount of its endogenous GLP-1, and could lessen responsiveness to its effects," noted Dr. Adam Collins, a dietetics researcher.

"Discontinuation of this hormone supplement results in appetite is uncontrolled, making excessive eating a significant risk."

A Chronic Issue?

The NHS advise the jabs for individuals with obesity-related health risks, accompanied by prescribed lifestyle changes.

A number of clinicians contend that, given the significant potential of relapse, the treatment should be considered long-term.

This perspective is supported by drug manufacturers, who note that the findings "underscore the long-term nature of excess weight," akin to managing conditions like hypertension.

Patient Experiences

Users who have stopped the medication explain a intense return of appetite.

"I experienced a switch flipping and I was suddenly starving," described one woman.

This challenge is compounded if individuals have not established sustainable lifestyle or habit changes during therapy.

Widespread Use

Figures suggest that millions of people in the UK have tried weight-loss jabs in the past year, with interest being substantial.

  • Use is greater among females than males.
  • The middle-aged demographic shows the greatest usage rates.
  • A large proportion obtain the medications through private healthcare rather than public health services.

Ultimately, clinicians stress that while these medications are powerful agents for weight loss, they are not a permanent fix and maintained weight loss relies on combined behavioural management.

JL
By

Jacob Lewis

Child development specialist and play advocate with over 15 years of experience in early childhood education.

Modern Playhouse

Type to search articles.